Tina Ventura
Investor Relations Contact chez MADRIGAL PHARMACEUTICALS, INC.
Profil
Tina Ventura is currently the Director at Lake Forest Open Lands Association, a Trustee at Lake Forest Country Day School, and the Chief Investor Relations Officer at Madrigal Pharmaceuticals, Inc. She previously worked as the Chief Investor Relations Officer & Senior VP at Horizon Therapeutics Plc.
Ventura received an undergraduate degree from Northwestern University and an MBA from Loyola University of Chicago.
Postes actifs de Tina Ventura
| Sociétés | Poste | Début |
|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Investor Relations Contact | 29/01/2024 |
| Lake Forest Open Lands Association | Director/Board Member | - |
| Lake Forest Country Day School | Director/Board Member | - |
Anciens postes connus de Tina Ventura
| Sociétés | Poste | Fin |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Investor Relations Contact | - |
Formation de Tina Ventura
| Northwestern University | Undergraduate Degree |
| Loyola University of Chicago | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
| Lake Forest Open Lands Association |
